What a patient brochure may and may not carry in India
Patient material promoting a medicine is advertising to the public. The Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 bars advertising any drug for the purposes in its Section 3. These include the diagnosis, cure, mitigation, treatment or prevention of conditions in its Schedule, prescription or not. Section 4 bars false or misleading drug advertisements. The Drugs and Cosmetics Rules 1945, also bar advertising Schedule H, H1 and X drugs without previous Central Government sanction.
In short
- Two drug-specific restrictions apply together. One is the Drugs and Magic Remedies Act 1954. The other is a Drugs and Cosmetics Rules 1945 licence condition: no advertisement of Schedule H, H1 or X drugs without previous Central Government sanction (for example Rule 74(p)).
- The Schedule to the Drugs and Magic Remedies Act lists diseases and conditions, and rules under the Act can add more. No drug may be advertised for their diagnosis, cure, mitigation, treatment or prevention.
- That restriction applies to non-prescription products too.
- Indian law defines no statutory 'over-the-counter' category for medicines.
- UCPMP Clause 3.2 applies to material whose purpose is to inform a prescribing decision by persons qualified to prescribe. So its five items are not the patient-material list. The general clauses of UCPMP 2024, such as Clauses 1.3 and 2.2, carry no such limit.
The instruments that restrict patient advertising
Two drug-specific instruments restrict advertising medicines to the public in India. The first is a condition of the licence to manufacture drugs for sale or distribution. Rule 74(p) of the Drugs and Cosmetics Rules 1945 is one example. It says no advertisement of Schedule H, H1 and X drugs 'shall be made except with the previous sanction of the Central Government'. The same condition appears in Rule 78(q) and in other licence conditions. The second is the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954. It bars advertising any drug for the purposes in its Section 3 and the conditions in its Schedule, whatever the drug's schedule. Its Section 4 bars false or misleading drug advertisements.
The Drugs and Cosmetics Rules 1945 also say no drug may 'purport or claim to prevent or cure' the diseases or ailments in Schedule J (Rule 106). That rule sits in the Part of the Rules on labelling and packing. Its words 'convey to the intending user thereof any idea' are commonly read to reach promotional claims. Other instruments apply alongside them. The Consumer Protection Act 2019 applies, with the Central Consumer Protection Authority's Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022. The self-regulatory ASCI Code also applies.
The Schedule is the part people miss
The Drugs and Magic Remedies Act carries a Schedule of diseases and conditions. Rules under the Act can add further conditions. Section 3(d) bars advertising a drug in terms that suggest its use for 'the diagnosis, cure, mitigation, treatment or prevention' of any of them. A product that does not require a prescription is still caught. The common error is to reason that a freely sold medicine makes a patient leaflet unrestricted. What decides it is whether the piece links a drug to a Scheduled condition.
There is no 'OTC' category in Indian law
Neither the Drugs and Cosmetics Act 1940 nor the Drugs and Cosmetics Rules 1945 define an over-the-counter class. The Rules have many schedules. Only some of them, such as Schedules H, H1 and X, tie a medicine to sale on prescription. The Drugs and Magic Remedies Act applies to every drug, whatever its schedule. Treating 'OTC' as a category that permits patient advertising leads to a piece nobody can approve.
Frequently asked questions
What restricts advertising prescription medicines to patients in India?
Two drug-specific instruments do. Under the Drugs and Cosmetics Rules 1945, a manufacturing licence condition bars advertising Schedule H, H1 and X drugs without previous Central Government sanction. Examples are Rule 74(p) and Rule 78(q). Separately, the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 bars advertising any drug for the purposes in its Section 3 and Schedule. That bar applies whether or not the drug needs a prescription.
Does India have an OTC category where patient advertising is allowed?
No. Indian law defines no statutory over-the-counter category. Every drug, whatever its schedule, is subject to the Drugs and Magic Remedies Act. That includes its Schedule of conditions for which no drug may be advertised for diagnosis, cure, mitigation, treatment or prevention.
Does UCPMP Clause 3.2 apply to a patient brochure?
No. Clause 3.2 is scoped to material that gives persons qualified to prescribe information for a prescribing decision. A patient brochure that promotes a medicine is advertising to the public. The Drugs and Magic Remedies Act and the Consumer Protection Act framework apply to it. So do the Drugs and Cosmetics Rules 1945: the Schedule H, H1 and X advertising condition, and Rule 106 with Schedule J. Rule 106 is a labelling rule commonly read to reach promotional claims. The self-regulatory ASCI Code applies alongside. The general clauses of UCPMP 2024, such as Clauses 1.3 and 2.2, are not limited to prescribers.
Check it before MLR does
Collateral Advisor reviews each page you upload across five dimensions: medical, compliance, visual design, copywriting and best practice.
Free trial, no card needed. MarketingSense is a pre-MLR advisory assistant. Your medical, legal and regulatory team still makes the final call.